Esophageal Adenocarcinoma Methods and Protocols

255

References

1. Suzuki MM, Bird A (2008) DNA methylation
   landscapes: provocative insights from epig-
   enomics. Nat Rev Genet 9:465–476


2. Sharma S, Kelly TK, Jones PA (2010)
   Epigenetics in cancer. Carcinogenesis 31:27–36


3. Feinberg AP, Tycko B (2004) The history of
   cancer epigenetics. Nat Rev Cancer 4:143–153


4. Kailasam A, Mittal SK, Agrawal DK (2015)
   Epigenetics in the pathogenesis of esophageal
   adenocarcinoma. Clin Transl Sci 8:394–402


5. Agarwal A, Polineni R, Hussein Z, Vigoda I,
   Bhagat TD, Bhattacharyya S, Maitra A, Verma
   A (2012) Role of epigenetic alterations in the
   pathogenesis of Barrett's esophagus and esoph-
   ageal adenocarcinoma. Int J Clin Exp Pathol
   5:382–396


6. Peng D, Hu TL, Jiang A, Washington MK,
   Moskaluk CA, Schneider-Stock R, El-Rifai W
   (2011) Location-specific epigenetic regulation
   of the metallothionein 3 gene in esophageal
   adenocarcinomas. PLoS One 6:e22009


7. Kaz AM, Grady WM (2014) Epigenetic bio-
   markers in esophageal cancer. Cancer Lett
   342:193–199


8. Wong DJ, Barrett MT, Stoger R et al (1997)
   p16INK4a promoter is hypermethylated at a
   high frequency in esophageal adenocarcino-
   mas. Cancer Res 57:2619–2622


9. Klump B, Hsieh CJ, Holzmann K, Gregor M,
   Porschen R (1998) Hypermethylation of the
   CDKN2/p16 promoter during neoplastic pro-
   gression in Barrett’s esophagus.
   Gastroenterology 115:1381–1386


10. Eads CA, Lord RV, Wickramasinghe K, Long
    TI, Kurumboor SK, Bernstein L, Peters JH,
    DeMeester SR, DeMeester TR, Skinner KA,
    Laird PW (2001) Epigenetic patterns in the
    progression of esophageal adenocarcinoma.
    Cancer Res 61:3410–3418


11. Wild Christopher P, Hardie LJ (2003)
    Molecular events associated with the develop-
    ment of Barrett’s esophagus and esophageal
    adenocarcinoma. Nat Rev Cancer 3:676–684


12. Xu E, Gu J, Hawk ET, Wang KK, Lai M,
    Huang M, Ajani J, Wu X (2013) Genome-wide
    methylation analysis shows similar patterns in
    Barrett's esophagus and esophageal adenocar-
    cinoma. Carcinogenesis 34:2750–2756


13. Corn PG, Heath EI, Heitmiller R, Fogt F,
    Forastiere AA, Herman JG, Wu TT (2001)
    Frequent hypermethylation of the 5′ CpG
    island of E-cadherin in esophageal adenocarci-
    noma. Clin Cancer Res 7:2765–2769
    14. Kuester D, El-Rifai W, Peng D, Ruemmele P,
    Kroeckel I, Peters B, Moskaluk CA, Stolte M,
    Mönkemüller K, Meyer F, Schulz HU,
    Hartmann A, Roessner A, Schneider-Stock R
    (2009) Silencing of MGMT expression by pro-
    moter hypermethylation in the metaplasia-
    dysplasia- carcinoma sequence of Barrett’s
    esophagus. Cancer Lett 275:117–126
    15. Smith E, Ruszkiewicz AR, Jamieson GG, Drew
    PA (2014) IGFBP7 is associated with poor
    prognosis in esophageal adenocarcinoma and is
    regulated by promoter DNA methylation. Br
    J Cancer 110:775–782
    16. Brock MV, Gou M, Akiyama Y, Muller A, Wu
    TT, Montgomery E, Deasel M, Germonpré P,
    Rubinson L, Heitmiller RF, Yang SC, Forastiere
    AA, Baylin SB, Herman JG (2003) Prognostic
    importance of promoter hypermethylation of
    multiple genes in esophageal adenocarcinoma.
    Clin Cancer Res 9:2912–2919
    17. Wang JS, Guo M, Montgomery EA, Thompson
    RE, Cosby H, Hicks L, Wang S, Herman JG,
    Canto MI (2009) DNA promoter hypermeth-
    ylation of p16 and APC predicts neoplastic
    progression in Barrett’s esophagus. Am
    J Gastroenterol 104:2153–2160
    18. Kuester D, Dar AA, Moskaluk CC, Krueger S,
    Meyer F, Hartig R, Stolte M, Malfertheiner P,
    Lippert H, Roessner A, El-Rifai W, Schneider-
    Stock R (2007) Early involvement of death-
    associated protein kinase promoter
    hypermethylation in the carcinogenesis of
    Barrett’s esophageal adenocarcinoma and its
    association with clinical progression. Neoplasia
    9:236–245
    19. Jin Z, Cheng Y, Olaru A, Kan T, Yang J, Paun
    B, Ito T, Hamilton JP, David S, Agarwal R,
    Selaru FM, Sato F, Abraham JM, Beer DG,
    Mori Y, Shimada Y, Meltzer SJ (2008)
    Promoter hypermethylation of CDH13 is a
    common, early event in human esophageal
    adenocarcinogenesis and correlates with
    clinical risk factors. Int J Cancer 123:
    2331–2336
    20. Jin Z, Mori Y, Yang J, Sato F, Ito T, Cheng Y,
    Paun B, Hamilton JP, Kan T, Olaru A, David S,
    Agarwal R, Abraham JM, Beer D, Montgomery
    E, Meltzer SJ (2007) Hypermethylation of the
    nel-like 1 gene is a common and early event
    and is associated with poor prognosis in early-
    stage esophageal adenocarcinoma. Oncogene
    26:6332–6340
    21. Tischoff I, Hengge UR, Vieth M, Ell C, Stolte
    M, Weber A, Schmidt WE, Tannapfel A (2007)

DNA Methylation in Esophageal Adenocarcinoma